Juvena Therapeutics

Juvena Therapeutics company information, Employees & Contact Information

Updated June 2026

Quick answer

Juvena Therapeutics is a Biotechnology Research company and founded in 2017. It has approximately 46 employees on record. Contact data was last refreshed in June 2026. Find Juvena Therapeutics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Decoding Secreted Proteins for Chronic and Age-Related Diseases

Company Details

Employees
46
Founded
2017
Address
Palo Alto, Ca 94304, Us
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Palo Alto, CA
Looking for a particular Juvena Therapeutics employee's phone or email?

Juvena Therapeutics Questions

News

NIA Small Business Showcase: Juvena Therapeutics, Inc. - National Institute on Aging (.gov)

NIA Small Business Showcase: Juvena Therapeutics, Inc. National Institute on Aging (.gov)

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health - GlobeNewswire

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health GlobeNewswire

Eli Lilly, Juvena Therapeutics Partner to Develop Muscle-Boosting Drugs Using AI Platform - Yahoo Finance

Eli Lilly, Juvena Therapeutics Partner to Develop Muscle-Boosting Drugs Using AI Platform Yahoo Finance

Best Kept Secret-Ome: Juvena Therapeutics and Lilly Partner on Muscle Health - Inside Precision Medicine

Best Kept Secret-Ome: Juvena Therapeutics and Lilly Partner on Muscle Health Inside Precision Medicine

Juvena Therapeutics and Lilly collaborate on muscle health drugs - The Pharma Letter

Juvena Therapeutics and Lilly collaborate on muscle health drugs The Pharma Letter

Juvena Therapeutics Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases - Business Wire

Juvena Therapeutics Secures $41 Million to Accelerate the Discovery and Development of Biologics for Chronic and Age-Related Diseases Business Wire

How a daughter of refugees founded a biotech to combat diseases that have afflicted her family - The Business Journals

How a daughter of refugees founded a biotech to combat diseases that have afflicted her family The Business Journals

Biotech Startup Juvena Therapeutics Nabs $41 Million for Protein Drugs - The Wall Street Journal

Biotech Startup Juvena Therapeutics Nabs $41 Million for Protein Drugs The Wall Street Journal

Juvena Therapeutics Receives FDA Orphan Drug Designation for JUV-161 for the Treatment of Myotonic Dystrophy Type 1 - Business Wire

Juvena Therapeutics Receives FDA Orphan Drug Designation for JUV-161 for the Treatment of Myotonic Dystrophy Type 1 Business Wire

Top Juvena Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant